p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer
Year: 1995
Type: article
Study design: Observational Study
Source: Human Molecular Genetics
DOI: 10.1093/hmg/4.9.1569
Institution: Marie Curie
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Marie Curie
OpenAlex ID: W2135687675
